Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
LPS-B5 (LPS from E. coli 055:B5) Macrophage-HIF1α signaling in carotid artery stenosis. 2021 Am J Pathol. Kim G.D. et al. DOI: 10.1016/j.ajpath.2021.03.008
Imiquimod VacciGrade™ Imiquimod accelerated antitumor response by targeting lysosome adaptation in ... 2021 J Invest Dermatol. Chang S.H. et al. DOI: 10.1016/j.jid.2021.01.034
LPS-EB (LPS from E. coli O111:B4) Production of IL-1β, IL-6 and CXCL8 by endometrium of crossbred heifers stimu... 2021 Anim Reprod Sci. Pimenta Nunes P. et al. DOI: 10.1016/j.anireprosci.2021.106736
Plasmocin™ - Mycoplasma Elimination Reagent Local administration of porcine immunomodulatory, chemotactic and angiogenic ... 2021 Bioact Mater. Monguió-Tortajada M. et al. DOI: 10.1016/j.bioactmat.2021.02.026
Puromycin FOXP1 drives osteosarcoma development by repressing P21 and RB transcription ... 2021 Oncogene Li H. et al. DOI: 10.1038/s41388-021-01742-4
ADU-S100 Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... 2021 Front Oncol. Esteves A.M. DOI: 10.3389/fonc.2021.621550
2'3'-cGAMP Control Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... 2021 Front Oncol. Esteves A.M. DOI: 10.3389/fonc.2021.621550
2'3'-c-di-AM(PS)2 (Rp,Rp) VacciGrade™ Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... 2021 Front Oncol. Esteves A.M. DOI: 10.3389/fonc.2021.621550
PMA Ex vivo characterization of Breg cells in patients with chronic Chagas disease. 2021 Sci Rep. Girard M.C. et al. DOI: 10.1038/s41598-021-84765-x
C14-Tri-LAN-Gly NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... 2021 Front Immunol. Jia F. et al. DOI: 10.3389/fimmu.2021.603192
C12-iE-DAP NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... 2021 Front Immunol. Jia F. et al. DOI: 10.3389/fimmu.2021.603192
IFN-α/β Reporter HEK 293 Cells S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... 2021 J Transl Autoimmun Duguet F. et al. DOI: 10.1016/j.jtauto.2021.100093
Blasticidin S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... 2021 J Transl Autoimmun Duguet F. et al. DOI: 10.1016/j.jtauto.2021.100093
QUANTI-Blue™ S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... 2021 J Transl Autoimmun Duguet F. et al. DOI: 10.1016/j.jtauto.2021.100093
Zeocin™ S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... 2021 J Transl Autoimmun Duguet F. et al. DOI: 10.1016/j.jtauto.2021.100093
LPS-B5 (LPS from E. coli 055:B5) GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... 2021 PLoS One. Pulsipher A. et al. DOI: 10.1371/journal.pone.0249343
Pam3CSK4 GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... 2021 PLoS One. Pulsipher A. et al. DOI: 10.1371/journal.pone.0249343
QUANTI-Luc™ GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... 2021 PLoS One. Pulsipher A. et al. DOI: 10.1371/journal.pone.0249343
THP1-HMGB1-Lucia™ Cells GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... 2021 PLoS One. Pulsipher A. et al. DOI: 10.1371/journal.pone.0249343
QUANTI-Blue™ GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... 2021 PLoS One. Pulsipher A. et al. DOI: 10.1371/journal.pone.0249343

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty